Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis

Justin Loloi, Ian C. Gilchrist

Research output: Contribution to journalEditorial

1 Scopus citations

Abstract

Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.

Original languageEnglish (US)
Pages (from-to)16-17
Number of pages2
JournalCatheterization and Cardiovascular Interventions
Volume92
Issue number1
DOIs
StatePublished - Jul 2018

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis'. Together they form a unique fingerprint.

Cite this